Skip to main content
. 2015 Mar 16;6(11):9125–9139. doi: 10.18632/oncotarget.3273

Figure 3. miR-155 expression is associated with overall survival in chordoma patients.

Figure 3

(A) Kaplan-Meier analysis comparing overall survival between chordoma patients with miR-155 expression below the median value (↓ miR-155 group), and chordoma patients with at least median miR-155 expression (↑ miR-155 group). (B) Kaplan-Meier analysis comparing metastasis-free survival of chordoma patients stratified as in (A). (C) Kaplan-Meier analysis comparing overall survival of chordoma patients stratified by both miR-1 and miR-155 expression (using median expression level cutoffs for each miRNA separately).